Evaluation of 24 protocols for the production of platelet-rich fibrin

  • PDF / 5,152,004 Bytes
  • 13 Pages / 595.276 x 790.866 pts Page_size
  • 42 Downloads / 174 Views

DOWNLOAD

REPORT


RESEARCH ARTICLE

Open Access

Evaluation of 24 protocols for the production of platelet‑rich fibrin Richard J. Miron1,2*†  , Jihua Chai1†, Masako Fujioka‑Kobayashi3, Anton Sculean2 and Yufeng Zhang1,4*

Abstract  Background:  The aim of this study was to evaluate 24 protocols for the production of platelet rich fibrin (PRF) produced via horizontal centrifugation to better understand cell separation following protocols at various times and speeds. Methods:  All protocols were compared utilizing a recent method to quantify cells in PRF in 1 mL sequential layers pipetted from the upper layer downwards until all 10 mL were harvested. In total, 960 complete blood counts (CBCs) were investigated. Both solid and liquid-based PRF protocols were investigated following 24 protocols involving 6 rel‑ ative centrifugal force (RCF) values (100, 200, 400, 700, 1000 and 1200g) at 4 centrifugation times (3, 5, 8 and 12 min). Results:  In general, platelets could more easily accumulate in the upper 4 layers when compared to leukocytes owing to their lower cellular density. Protocol time seemed to have a greater impact on the final cell layer separation when compared to the effect of speed. Protocols of greater than 8 min at 400g led to no leukocyte accumulation in the upper PRF layers (found specifically within the buffy coat). Protocols at or below 200g were unable to effectively accumulate platelets/leukocytes. The optimal centrifugation speed and time for solid-PRF ranged between 400 and 700g for 8 min. It was noted that variability in patient baseline platelet/leukocyte/erythrocyte counts (hematocrit) significantly affected cell layer separation. This finding was more pronounced at lower centrifugation speeds. Conclusions:  Within the investigated ranges, a protocol of 700g for 8 min presented the highest yield of platelets/ leukocytes evenly distributed throughout the upper PRF layers. Keywords:  Advanced platelet-rich fibrin, Leukocyte and platelet-rich fibrin, A-PRF, i-PRF, L-PRF Background Platelet concentrates, including platelet-rich plasma (PRP) and platelet-rich fibrin (PRF), have been widely utilized in many fields of medicine as a scaffold capable of facilitating tissue regeneration [1]. PRP was first introduced over 20  years ago as a specific regenerative modality aimed at concentrating platelets from whole blood [2–6]. PRP contains an array of naturally derived *Correspondence: [email protected]; [email protected] † Richard J. Miron and Jihua Chai contributed equally to this work 1 The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei‑MOST) and Key Laboratory of Oral Biomedicine Ministry of Education, School and Hospital of Stomatology, Wuhan University, Wuhan, China Full list of author information is available at the end of the article

autologous growth factors, including platelet-derived growth factor (PDGF), transforming growth factor beta (TGF-β), and vascular endothelial growth factor (VEGF). This set of growth factors is responsible for facilitating new blood vessel formation (ang